2013
DOI: 10.3892/mmr.2013.1868
|View full text |Cite
|
Sign up to set email alerts
|

Development of a canine model with diffuse hepatic vein obstruction (Budd-Chiari syndrome) via endovascular occlusion

Abstract: Abstract. The aim of the present study was to develop a reliable and reproducible canine model to mimic human diffuse hepatic vein obstruction (Budd-Chiari syndrome, BCS). A total of 24 canines were divided into an experimental (n=18) and a control (n=6) group. Under the guidance of digital subtraction angiography, a balloon catheter was delivered to the target hepatic vein (the common trunk of the left hepatic and middle hepatic veins) via the right external jugular vein. The balloon was inflated to completel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Portal vein pressures were measured before PVE and after liver venous deprivation (end of the procedure). Right portal vein embolization was performed before hepatic vein embolization, because hepatic vein embolization reduces portal flow in the embolized segment making portal vein embolization more at risk for non-target embolization as demonstrated in two animal studies ( 15 , 16 ). Although both a left or right portal vein approach can be used for right PVE, we prefer using a contralateral approach, which makes the procedure technically easier (e.g., avoiding catheter kinking), and is safer in case of right liver biliary tree dilatation as observed in Klatskin tumors ( 17 ).…”
Section: Methodsmentioning
confidence: 99%
“…Portal vein pressures were measured before PVE and after liver venous deprivation (end of the procedure). Right portal vein embolization was performed before hepatic vein embolization, because hepatic vein embolization reduces portal flow in the embolized segment making portal vein embolization more at risk for non-target embolization as demonstrated in two animal studies ( 15 , 16 ). Although both a left or right portal vein approach can be used for right PVE, we prefer using a contralateral approach, which makes the procedure technically easier (e.g., avoiding catheter kinking), and is safer in case of right liver biliary tree dilatation as observed in Klatskin tumors ( 17 ).…”
Section: Methodsmentioning
confidence: 99%
“…After opening the abdominal cavity, the presence of varicose veins of the anterior abdominal wall, ascetic fluid in the abdominal cavity, and the presence of changes in the size of the liver and spleen were visually assessed. Indicators of abdominal circumference, the development of abdominal varicose veins, pathological changes in the liver and spleen, changes in liver function, and hypertension in the inferior vena cava were regarded as signs of a simulated Budd-Chiari syndrome, 6 as a control for this assessment, previously described information was also taken into account. 17…”
Section: Macroscopic Assessment Of the Abdominal Organsmentioning
confidence: 99%
“…4,5 The development of Budd-Chiari syndrome model was mainly achieved via surgical reduction of the diameter of the inferior vena cava or the occlusion of the hepatic branches by the endovascular method. [4][5][6] There are two options for imitating the Budd-Chiari syndrome: hepatic vein thrombosis (the so-called classic Budd-Chiari syndrome) and hepatic vena cava-Budd-Chiari syndrome. 7 The effect of hypertension on hepatic vessels has been well described for classical models, 8 including models based on the endovascular approach.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…There are several methods capable to reproduce one of the three types of portal hypertension (i.e., prehepatic and posthepatic), each with its own characteristics, results and applications 11 . Biliary tract ligation, hepatic artery embolization with 80% alcohol, infusion of non-radioactive colored tracer microspheres, intoxication by carbon tetrachloride (CCL4) and thioacetamide (TAA) are the most used intrahepatic portal hypertension models, while the gradual occlusion of the inferior vena cava (gOIVC) is the standard model for posthepatic portal hypertension [12][13][14][15][16][17][18][19] .…”
mentioning
confidence: 99%